Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Alternative treatment for secretory diarrhea revealed in a new class of CFTR inhibitors
Qais Al-Awqati
Qais Al-Awqati
Published December 1, 2002
Citation Information: J Clin Invest. 2002;110(11):1599-1601. https://doi.org/10.1172/JCI17301.
View: Text | PDF
Commentary

Alternative treatment for secretory diarrhea revealed in a new class of CFTR inhibitors

  • Text
  • PDF
Abstract

Commentary

Authors

Qais Al-Awqati

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Epithelial ion secretion: (a) Na+, K+, and 2 Cl– ions are transported in...
Epithelial ion secretion: (a) Na+, K+, and 2 Cl– ions are transported into the cell by the NaK2Cl cotransporter (NKCC). Na+ and K+ are recycled across the basolateral surface by the NaK-ATPase and a K+ channel, respectively. The activity of intracellular Cl– is above electrochemical equilibrium. The apical membrane contains the CFTR, a cyclic AMP-activated Cl– channel. When opened, CFTR-mediated Cl– secretion results in hyperpolarization of the epithelium leading to secretion of Na+ in between the cells. (b) The CFTR is inhibited by thiazolidinone derivatives. (c) In cystic fibrosis epithelia, the CFTR is either not delivered to the apical surface or cannot be opened by cyclic AMP. (d) In secretory diarrhea, an increase in cyclic AMP or cyclic GMP opens the CFTR and leads to increased Cl– secretion.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts